Prostate cancer is a slow growing cancerous tumor. It puts forth symptoms at a fairly advanced stage. However if people undertake yearly medical checkups including prostate cancer tests, (which they are supposed to do after 40) the chances of early stage detection of the same are bright.
John Hopkins Oncology Scientists and researches have found out a method to measure prostate cancer at a very early stage: Prostate cancer triggers certain genetic changes. If the chemical process associated with genetic change is measured, detection of prostate cancer becomes a possibility even at a very early stage. Early stage detection ensures complete cure of the malaise.
U.S and U.K scientists are simultaneously developing a quick test for prostate cancer. It will take only three minutes to perform. They collect the sample of prostate fluid via a small needle inserted in the patient's body under local anesthetic. This will be a landmark in testing of prostate cancer. Dr A Prasanna de Silva, chair of the organic chemistry at Queens University, Belfast, U.K said that the new test was "A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men".
The most popular test for cancer throughout the world is the Prostate specific Antigen (PSA) prostate cancer test. Prostate gland secretes a protein called PSA and if the secretion value is high, it is indicative of the presence of cancer forming cells. This test along with Digital Rectal Examination helps Physician to accurately measure the size of the prostate gland.
Maryland-based Pharmaceuticals Scientist have found that a protein - an enzyme called HAAH might prove to be a biomarker, which is more sensitive and specific than current methods of early detection of prostate cancer. This biomarker test may identify prostate cancer at an earlier stage. Always early detection of prostate cancer ensures complete cure of the cancer. This is very useful to prevent prostate cancer recurrence.
Through a simple DNA test, which identifies risk genes, the scientists at the Swedish medical University Karolinska Institutet hope that the men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer. Even the cases where the partial cure sets in, they say that the risk of prostate cancer recurrence is there.
Now let us look at the nanoparticle prostate cancer test. Here the golden nanoparticles are first mixed in a solution. Then the patrient's blood is dropped in the nano solution. Then the nano particles seek put the protein. In case of protein particles being present, then the protein particles surrounded by the nanoparticles. When there is cluster formation, cancer is present, is the inference. Otherwise in case of no cluster formation, obviously no cancer formation needs to be suspected.
The question whether obesity is an impediment for prostate cancer test has been studied deeply by the Texas University Health Science Center in San Antonio. They concluded that in obese men the sensitivity of PSA testing is blunted. What the Doctors conclude is that more estrogen is produced by obese men, affecting testosterone levels and could affect the cells that produce antigen in the test.
John Hopkins Oncology Scientists and researches have found out a method to measure prostate cancer at a very early stage: Prostate cancer triggers certain genetic changes. If the chemical process associated with genetic change is measured, detection of prostate cancer becomes a possibility even at a very early stage. Early stage detection ensures complete cure of the malaise.
U.S and U.K scientists are simultaneously developing a quick test for prostate cancer. It will take only three minutes to perform. They collect the sample of prostate fluid via a small needle inserted in the patient's body under local anesthetic. This will be a landmark in testing of prostate cancer. Dr A Prasanna de Silva, chair of the organic chemistry at Queens University, Belfast, U.K said that the new test was "A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men".
The most popular test for cancer throughout the world is the Prostate specific Antigen (PSA) prostate cancer test. Prostate gland secretes a protein called PSA and if the secretion value is high, it is indicative of the presence of cancer forming cells. This test along with Digital Rectal Examination helps Physician to accurately measure the size of the prostate gland.
Maryland-based Pharmaceuticals Scientist have found that a protein - an enzyme called HAAH might prove to be a biomarker, which is more sensitive and specific than current methods of early detection of prostate cancer. This biomarker test may identify prostate cancer at an earlier stage. Always early detection of prostate cancer ensures complete cure of the cancer. This is very useful to prevent prostate cancer recurrence.
Through a simple DNA test, which identifies risk genes, the scientists at the Swedish medical University Karolinska Institutet hope that the men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer. Even the cases where the partial cure sets in, they say that the risk of prostate cancer recurrence is there.
Now let us look at the nanoparticle prostate cancer test. Here the golden nanoparticles are first mixed in a solution. Then the patrient's blood is dropped in the nano solution. Then the nano particles seek put the protein. In case of protein particles being present, then the protein particles surrounded by the nanoparticles. When there is cluster formation, cancer is present, is the inference. Otherwise in case of no cluster formation, obviously no cancer formation needs to be suspected.
The question whether obesity is an impediment for prostate cancer test has been studied deeply by the Texas University Health Science Center in San Antonio. They concluded that in obese men the sensitivity of PSA testing is blunted. What the Doctors conclude is that more estrogen is produced by obese men, affecting testosterone levels and could affect the cells that produce antigen in the test.
About the Author:
No site but OnProstateCancer.com gives you all the tips and info on surviving prostate cancer and related subjects. Whether you are new to the subject or an expert, make sure to check out treating prostate cancer by following the links above !
